Active ingredientVernakalant HClCat. No. P-V032-001CAS 748810-28-8Family · Pharmaceutical analytical standards
Vernakalant
An antiarrhythmic that acts mainly on potassium and sodium channels in the atria: given by intravenous infusion, it rapidly restores normal rhythm in recent-onset atrial fibrillation. Approved in the European Union in September 2010. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?Its molecule has three asymmetric carbon atoms, so eight possible stereoisomers: the medicine contains only one of them, the RRR form.
Go to the active ingredient →Active ingredientVernakalant HClCat. No. P-V032-001CAS 748810-28-8
Isotopically labelledVernakalant-d6 HClCat. No. P-V032-002CAS 866455-16-5
ImpurityVernakalant Impurity 1 ((3S,1S,2S)-Isomer) HydrochlorideCat. No. P-V032-003CAS 795282-00-7
ImpurityVernakalant Impurity 2 ((3R,1S,2R)-Isomer)Cat. No. P-V032-004CAS 795282-27-8
ImpurityVernakalant Impurity HCl (3R,1S,2S)Cat. No. P-V032-008CAS 795281-93-5
ImpurityVernakalant Impurity HCl (3S,1R,2R)Cat. No. P-V032-009CAS 795281-99-1No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.